Andreas M.
- Country
- Germany
- Department
- Neuroscience Clinical Research Center
Research Overview
- Evaluation of Gefurulimab (ALXN1720) Efficacy and Safety in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Comparative Effectiveness of Levetiracetam and Valproate Semisodium in Benzodiazepine-Resistant Status Epilepticus in Patients Aged 65 and Older
- Phase 3B Randomized Study on Efgartigimod Alfa IV Dosing Regimens in Generalized Myasthenia Gravis Patients
Data & Insights
Has run more than one trial at 20 of 83 partner sites.
Specializations
Neuromuscular Disorders
The investigator demonstrates significant expertise in treating myasthenia gravis, with particular focus on both generalized and ocular manifestations of the condition. Their research encompasses innovative therapeutic approaches for managing autoimmune neuromuscular junction disorders.
- Generalized Myasthenia Gravis (gMG)
- Ocular Myasthenia Gravis (oMG)
- AChR Antibody-Positive MG
Primary interest in evaluating novel biological therapies and targeted treatments for myasthenia gravis patients.
Neurological Emergency Medicine
The investigator specializes in the management of acute neurological conditions, with particular emphasis on status epilepticus in elderly populations. Their work focuses on emergency interventions for severe neurological presentations.
- Established Status Epilepticus
- Benzodiazepine-Resistant Seizures
- Geriatric Neurology
Expertise in treating complex neurological emergencies in elderly patients requiring immediate intervention.
Therapeutic Development
The investigator is involved in evaluating innovative biological therapies for autoimmune neurological conditions. Their research includes assessment of various administration routes and dosing strategies for novel therapeutic agents.
- Complement Inhibition Therapy
- Subcutaneous Administration Studies
- Combination Therapy Approaches
Focus on developing optimized treatment regimens and delivery methods for neurological therapeutics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
